PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IQVIA Holdings Inc. (IQV)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US46266C1053

CUSIP

46266C1053

Sector

Healthcare

IPO Date

May 9, 2013

Highlights

Market Cap

$26.17B

EPS (TTM)

$7.49

PE Ratio

19.82

PEG Ratio

0.80

Total Revenue (TTM)

$11.67B

Gross Profit (TTM)

$3.81B

EBITDA (TTM)

$2.63B

Year Range

$135.97 - $252.88

Target Price

$223.21

Short %

2.07%

Short Ratio

2.02

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
IQV vs. IPG IQV vs. SPY IQV vs. VUG IQV vs. NVDA IQV vs. UNH IQV vs. VOO IQV vs. IDXX IQV vs. AMZN IQV vs. LLY IQV vs. COST
Popular comparisons:
IQV vs. IPG IQV vs. SPY IQV vs. VUG IQV vs. NVDA IQV vs. UNH IQV vs. VOO IQV vs. IDXX IQV vs. AMZN IQV vs. LLY IQV vs. COST

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in IQVIA Holdings Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


200.00%250.00%300.00%350.00%400.00%450.00%NovemberDecember2025FebruaryMarchApril
252.51%
224.33%
IQV (IQVIA Holdings Inc.)
Benchmark (^GSPC)

Returns By Period

IQVIA Holdings Inc. had a return of -24.46% year-to-date (YTD) and -35.22% in the last 12 months. Over the past 10 years, IQVIA Holdings Inc. had an annualized return of 8.35%, while the S&P 500 had an annualized return of 9.77%, indicating that IQVIA Holdings Inc. did not perform as well as the benchmark.


IQV

YTD

-24.46%

1M

-19.72%

6M

-36.31%

1Y

-35.22%

5Y*

2.45%

10Y*

8.35%

^GSPC (Benchmark)

YTD

-10.30%

1M

-7.04%

6M

-9.70%

1Y

4.44%

5Y*

12.96%

10Y*

9.77%

*Annualized

Monthly Returns

The table below presents the monthly returns of IQV, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20252.47%-6.24%-6.62%-15.80%-24.46%
2024-10.01%18.70%2.32%-8.35%-5.47%-3.49%16.45%2.16%-5.80%-13.15%-2.42%-2.16%-15.07%
202311.97%-9.13%-4.60%-5.36%4.61%14.15%-0.45%-0.51%-11.62%-8.09%18.40%8.07%12.93%
2022-13.20%-6.04%0.47%-5.72%-1.26%0.81%10.73%-11.49%-14.82%15.75%3.98%-6.02%-27.38%
2021-0.76%8.43%0.18%21.51%2.33%0.90%2.22%4.86%-7.77%9.13%-0.88%8.88%57.47%
20200.48%-10.15%-22.68%32.20%4.86%-5.11%11.64%3.38%-3.74%-2.31%9.74%6.02%15.96%
201911.05%8.60%2.68%-3.44%-2.20%18.44%-1.08%-2.53%-3.72%-3.32%1.08%5.84%33.00%
20184.38%-3.78%-0.22%-2.40%3.31%0.90%22.16%4.22%2.09%-5.25%1.74%-7.12%18.66%
20173.21%-1.40%4.06%4.66%2.56%3.54%1.17%6.05%-1.00%13.71%-5.63%-4.03%28.73%
2016-11.40%3.09%3.81%6.10%-1.71%-3.79%18.86%-0.44%4.86%-11.50%7.10%-1.02%10.76%
20152.77%7.40%3.06%-1.63%5.81%4.16%5.66%-2.88%-6.63%-8.51%6.82%0.99%16.63%
20142.78%13.69%-6.24%-7.17%8.17%4.53%3.08%2.17%-0.61%4.95%-1.23%1.82%27.04%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of IQV is 6, meaning it’s performing worse than 94% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of IQV is 66
Overall Rank
The Sharpe Ratio Rank of IQV is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of IQV is 66
Sortino Ratio Rank
The Omega Ratio Rank of IQV is 88
Omega Ratio Rank
The Calmar Ratio Rank of IQV is 1010
Calmar Ratio Rank
The Martin Ratio Rank of IQV is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for IQVIA Holdings Inc. (IQV) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for IQV, currently valued at -1.12, compared to the broader market-2.00-1.000.001.002.003.00
IQV: -1.12
^GSPC: 0.22
The chart of Sortino ratio for IQV, currently valued at -1.61, compared to the broader market-6.00-4.00-2.000.002.004.00
IQV: -1.61
^GSPC: 0.44
The chart of Omega ratio for IQV, currently valued at 0.80, compared to the broader market0.501.001.502.00
IQV: 0.80
^GSPC: 1.06
The chart of Calmar ratio for IQV, currently valued at -0.73, compared to the broader market0.001.002.003.004.00
IQV: -0.73
^GSPC: 0.22
The chart of Martin ratio for IQV, currently valued at -2.09, compared to the broader market-5.000.005.0010.0015.0020.00
IQV: -2.09
^GSPC: 1.02

The current IQVIA Holdings Inc. Sharpe ratio is -1.12. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of IQVIA Holdings Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
-1.12
0.22
IQV (IQVIA Holdings Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


IQVIA Holdings Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-47.48%
-14.13%
IQV (IQVIA Holdings Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the IQVIA Holdings Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the IQVIA Holdings Inc. was 49.43%, occurring on Mar 23, 2020. Recovery took 114 trading sessions.

The current IQVIA Holdings Inc. drawdown is 47.48%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-49.43%Feb 13, 202027Mar 23, 2020114Sep 2, 2020141
-49.32%Dec 31, 2021822Apr 10, 2025
-29.32%Jul 30, 2015133Feb 8, 2016159Sep 23, 2016292
-19.17%Sep 28, 201860Dec 24, 201833Feb 12, 201993
-14.91%Feb 20, 201453May 6, 201441Jul 3, 201494

Volatility

Volatility Chart

The current IQVIA Holdings Inc. volatility is 17.21%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%NovemberDecember2025FebruaryMarchApril
17.21%
13.66%
IQV (IQVIA Holdings Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of IQVIA Holdings Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how IQVIA Holdings Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.080.0100.0
IQV: 19.8
The chart displays the Price-to-Earnings (P/E) ratio for IQV, comparing it with other companies in the Diagnostics & Research industry. Currently, IQV has a P/E ratio of 19.8. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
1.02.03.04.05.0
IQV: 0.8
The chart shows the Price/Earnings to Growth (PEG) ratio for IQV compared to other companies in the Diagnostics & Research industry. IQV currently has a PEG ratio of 0.8. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
2.04.06.08.010.0
IQV: 1.7
This chart shows the Price-to-Sales (P/S) ratio for IQV relative to other companies in the Diagnostics & Research industry. Currently, IQV has a P/S ratio of 1.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
2.04.06.08.010.0
IQV: 4.3
The chart illustrates the Price-to-Book (P/B) ratio for IQV in comparison with other companies in the Diagnostics & Research industry. Currently, IQV has a P/B value of 4.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for IQVIA Holdings Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab